Vaccines for the Prevention of Coronavirus Disease 2019 in Older Adults

Institutionalized and community-dwelling older adults have been greatly impacted by the coronavirus disease 2019 (COVID-19) pandemic with increased morbidity and mortality. The advent of vaccines and their widespread use in this population has brought about a dramatic turnaround in COVID-19 outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Oyebanji, Oladayo A., Mylonakis, Eleftherios, Canaday, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Health Sciences Division 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633624/
https://www.ncbi.nlm.nih.gov/pubmed/36805013
http://dx.doi.org/10.1016/j.idc.2022.11.002
Descripción
Sumario:Institutionalized and community-dwelling older adults have been greatly impacted by the coronavirus disease 2019 (COVID-19) pandemic with increased morbidity and mortality. The advent of vaccines and their widespread use in this population has brought about a dramatic turnaround in COVID-19 outcomes. The immunogenicity and effectiveness of the various vaccine options worldwide are discussed. Optimization of vaccine usage will still be important to maximize protection due to reduced initial immunity, development of variant strains, and fading of immunity over time. There are also lessons learned specific to older populations for future pandemics of novel pathogens.

Ejemplares similares